营养来源模式对血液造血干细胞移植后减肥和BMI降低的影响
Francesco Paolo Tambaro1, Francesco Fabozzi1, Riccardo Masetti2,3
1Pediatric Oncology, Hematology and Cell Therapy, Azienda Ospedaliera di Rilievo Nazionale (AORN) Santobono Pausilipon, Napoli, Italy.
Frontiers in oncology
|March 13, 2026
概括
肠道营养 (EN) 最好支持儿科全源造血干细胞移植 (allo-HSCT) 患者的营养状况,尽量减少BMI下降和住院. 口服营养 (ON) 提供了中间的好处,而全方位肠道营养 (TPN) 显示了最不有利的结果.
科学领域:
- 儿科血液学/瘤学
- 移植医学 移植医学
- 营养科学 营养科学
背景情况:
- 营养状况不佳是儿科全源造血干细胞移植 (allo-HSCT) 的重要并发症,增加了患病率.
- 虽然肠道营养 (EN) 是首选的,但由于提供者和护理人员的限制,经常使用全肠道营养 (TPN).
- 口服营养 (ON) 是一种潜在的替代方案,但它在alo-HSCT接受者中的有效性需要进一步研究.
研究的目的:
- 追溯评估三个营养模式 - - 口服营养 (ON),肠道营养 (EN) 和亲肠道营养 (TPN) - - 对儿科Allo-HSCT接受者的营养状况的影响.
- 评估营养支持与关键的 allo-HSCT结果之间的关联,包括移植时间,住院时间和急性移植对宿主疾病 (aGvHD).
主要方法:
- 在意大利两个中心对125名接受allo-HSCT的儿科患者进行了回顾性分析.
- 根据初级营养支持对患者进行分类:TPN (n=41),ON (n=47) 和EN (n=37).
- 评估身体质量指数 (BMI) 的变化,移植时间,住院时间和严重aGvHD的发病率.
主要成果:
- 与ON和TPN组相比,接受EN的患者的BMI下降明显较小.
- TPN与最显著的BMI下降有关,而ON显示了中间结果.
- EN与最短的医院入院时间中位数有关;营养模式与aGvHD或移植时间无关.
结论:
- 肠道营养似乎是最有效的营养策略,以保持营养状况,减少住院治疗的儿科 allo-HSCT.
- 口服营养可以作为一个可行的替代方案,提供比TPN更好的结果.
- 需要进一步的研究来优化这种脆弱患者群体的营养支持策略.
相关概念视频
Bone Marrow Sampling and Transplants
2.2K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.2K
Stem Cell Therapy for Tissue Regeneration
4.8K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.8K
Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
Source And Potency Of Stem Cells
6.7K
Stem cells are undifferentiated cells with extensive self-renewal properties that help them maintain their population during the fetal and adult stages of life. They can specialize in all cell types of the human body. However, their differential potential may vary and can be classified into five types. Stem cells can be (1) Totipotent, (2) Pluripotent, (3) Multipotent, (4) Oligopotent, and (5) Unipotent. Each stem cell has a specific origin; the fertilized egg or zygote is a totipotent cell and...
6.7K
Role of Hematopoietic Growth Factors
4.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
4.2K
Multipotency of Hematopoietic Stem Cells
4.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
4.1K


